MBCOF
MARVEL BIOSCIENCES CORP by MARVEL BIOSCIENCES CORP. (MBCOF)
$12
About MARVEL BIOSCIENCES CORP by MARVEL BIOSCIENCES CORP. (MBCOF)
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. It develops several patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The company was founded on August 1, 2018 and is headquartered in Calgary, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.24
52 Week Low
$0.05
Market cap
6.8M
Dividend yield
0.00%
Volume
--
Avg. volume
12,211
P/E ratio
-3.61
MARVEL BIOSCIENCES CORP by MARVEL BIOSCIENCES CORP. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.24
52 Week Low
$0.05
Market cap
6.8M
Dividend yield
0.00%
Volume
--
Avg. volume
12,211
P/E ratio
-3.61